198 related articles for article (PubMed ID: 20113885)
41. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
[TBL] [Abstract][Full Text] [Related]
42. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
[TBL] [Abstract][Full Text] [Related]
43. Gene therapy for severe combined immune deficiency.
Qasim W; Gaspar HB; Thrasher AJ
Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
[TBL] [Abstract][Full Text] [Related]
44. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582
[TBL] [Abstract][Full Text] [Related]
45. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
46. Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.
Confer DL; Abress LK; Navarro W; Madrigal A
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S8-S11. PubMed ID: 19892026
[TBL] [Abstract][Full Text] [Related]
47. Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.
Horn B; Cowan MJ
J Allergy Clin Immunol; 2013 May; 131(5):1306-11. PubMed ID: 23622119
[TBL] [Abstract][Full Text] [Related]
48. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
Bacchetta R; Bigler M; Touraine JL; Parkman R; Tovo PA; Abrams J; de Waal Malefyt R; de Vries JE; Roncarolo MG
J Exp Med; 1994 Feb; 179(2):493-502. PubMed ID: 7905018
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic cell transplantation for correction of primary immunodeficiencies.
Filipovich A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S49-S52. PubMed ID: 18724301
[TBL] [Abstract][Full Text] [Related]
50. Does haploidentical transplantation in children with primary immunodeficiencies have the potential to exploit donor NK cell alloreactivity?
Dal-Cortivo L; Ouachée-Chardin M; Hirsch I; Blanche S; Fischer A; Cavazzana-Calvo M; Caillat-Zucman S
Bone Marrow Transplant; 2004 Dec; 34(11):945-7. PubMed ID: 15489880
[TBL] [Abstract][Full Text] [Related]
51. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
Aversa F; Reisner Y; Martelli MF
Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
[TBL] [Abstract][Full Text] [Related]
52. Non-myeloablative stem cell transplantation for severe combined immunodeficiency--Omenn syndrome.
Rossi G; Zecca M; Giorgiani G; Bonetti F; De Stefano P; Locatelli F
Br J Haematol; 2004 May; 125(3):406-7. PubMed ID: 15086425
[No Abstract] [Full Text] [Related]
53. Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative?
Kalwak K; Wójcik D; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Pajdosz K; Socha P; Chybicka A
Transplant Proc; 2004 Jun; 36(5):1574-7. PubMed ID: 15251388
[TBL] [Abstract][Full Text] [Related]
54. Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.
Zhao XY; Chang YJ; Xu LP; Liu DH; Liu KY; Huang XJ
Bone Marrow Transplant; 2009 Dec; 44(11):721-8. PubMed ID: 19377516
[TBL] [Abstract][Full Text] [Related]
55. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling.
Nonami A; Miyamoto T; Kuroiwa M; Kunisaki Y; Kamezaki K; Takenaka K; Harada N; Teshima T; Harada M; Nagafuji K
Jpn J Clin Oncol; 2007 Dec; 37(12):969-72. PubMed ID: 18055567
[TBL] [Abstract][Full Text] [Related]
56. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team.
Tsuji Y; Imai K; Kajiwara M; Aoki Y; Isoda T; Tomizawa D; Imai M; Ito S; Maeda H; Minegishi Y; Ohkawa H; Yata J; Sasaki N; Kogawa K; Nagasawa M; Morio T; Nonoyama S; Mizutani S
Bone Marrow Transplant; 2006 Mar; 37(5):469-77. PubMed ID: 16435016
[TBL] [Abstract][Full Text] [Related]
57. Transient recovery of endogenous immune function following haploidentical peripheral stem cell transplantation in a patient with severe combined immunodeficiency without evidence of engraftment.
Levy J; Amar A; Brautbar C; Slavin S; Kapelushnik J
Acta Paediatr; 2000 Feb; 89(2):248-50. PubMed ID: 10709900
[No Abstract] [Full Text] [Related]
58. A tale of two SCIDs.
Shaw KL; Kohn DB
Sci Transl Med; 2011 Aug; 3(97):97ps36. PubMed ID: 21865536
[TBL] [Abstract][Full Text] [Related]
59. Who is the best donor for haploidentical stem cell transplantation?
Kongtim P; Ciurea SO
Semin Hematol; 2019 Jul; 56(3):194-200. PubMed ID: 31202430
[TBL] [Abstract][Full Text] [Related]
60. Late thymic deficiency after HLA-haploidentical hematopoietic stem cell transplantation for severe combined immunodeficiency.
Ege MJ; Schuetz C; Jacobsen EM; Müller-Langer SM; Furlan I; Sirin M; Pannicke U; Schwarz K; Debatin KM; Hönig M; Schulz A; Friedrich W
J Allergy Clin Immunol; 2019 Apr; 143(4):1623-1626.e13. PubMed ID: 30529243
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
